BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28186689)

  • 1. Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions.
    Agirbasli M; Göktay F; Peker I; Gunes P; Aker FV; Akkiprik M
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28186689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.
    Agirbasli M; Eren M; Eren F; Murphy SB; Serdar ZA; Seckin D; Zara T; Cem Mat M; Demirkesen C; Vaughan DE
    J Thromb Thrombolysis; 2011 Jul; 32(1):59-63. PubMed ID: 21311952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy.
    Apti Sengun O; Ergun T; Guctekin T; Alibaz Oner F
    Microvasc Res; 2023 Nov; 150():104591. PubMed ID: 37543163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.
    Gao Y; Jin H
    Int Wound J; 2020 Dec; 17(6):1902-1908. PubMed ID: 33043622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy.
    Espinel DPGS; Di Giacomo TB; Pincelli TP; Pereira NV; Sotto MN; Kirsner RS; Criado PR
    J Cutan Pathol; 2017 Dec; 44(12):1033-1037. PubMed ID: 28901563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.
    Antunes J; Filipe P; André M; Fraga A; Miltenyi G; Marques Gomes M
    Acta Derm Venereol; 2010; 90(1):91-2. PubMed ID: 20107738
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.
    Lemaire R; Burwell T; Sun H; Delaney T; Bakken J; Cheng L; Rebelatto MC; Czapiga M; de-Mendez I; Coyle AJ; Herbst R; Lafyatis R; Connor J
    Arthritis Rheumatol; 2016 Feb; 68(2):473-83. PubMed ID: 26414805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery.
    Shimomura M; Hinoi T; Ikeda S; Adachi T; Kawaguchi Y; Tokunaga M; Sasada T; Egi H; Tanabe K; Okajima M; Ohdan H
    Surgery; 2013 Mar; 153(3):344-56. PubMed ID: 23218127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 mRNA expression in cultured pigmented ciliary epithelial cells of the porcine eye.
    Meyer MW; von Depka M; Wilhelm C; Schröder A; Erb C
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):679-86. PubMed ID: 12192463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys.
    Delarue F; Hertig A; Alberti C; Vigneau C; Ammor M; Berrou J; Akposso K; Peraldi MN; Rondeau E; Sraer JD
    Transplantation; 2001 Oct; 72(7):1256-61. PubMed ID: 11602852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue.
    Ekström M; Liska J; Eriksson P; Sverremark-Ekström E; Tornvall P
    Thromb Haemost; 2012 Sep; 108(3):485-92. PubMed ID: 22740034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells.
    Piquette GN; Crabtree ME; el-Danasouri I; Milki A; Polan ML
    J Clin Endocrinol Metab; 1993 Feb; 76(2):518-23. PubMed ID: 8432798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of fibrinolytic components in nasal mucosa.
    Sejima T; Madoiwa S; Mimuro J; Sugo T; Ishida T; Ichimura K; Sakata Y
    Histochem Cell Biol; 2004 Jul; 122(1):61-73. PubMed ID: 15197554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases.
    Tubone MQ; Escobar GF; Peruzzo J; Schestatsky P; Maldonado G
    An Bras Dermatol; 2013; 88(6 Suppl 1):227-9. PubMed ID: 24346927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
    Witzel ID; Milde-Langosch K; Wirtz RM; Roth C; Ihnen M; Mahner S; Zu Eulenburg C; Jänicke F; Müller V
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1709-18. PubMed ID: 20204407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins.
    Arnman V; Nilsson A; Stemme S; Risberg B; Rymo L
    Thromb Res; 1994 Dec; 76(5):487-99. PubMed ID: 7900096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.